LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
AstraZeneca, a mega-cap growth stock that just got cheaper!
Investing Articles
The AstraZeneca share price dips as the company raises full-year guidance!
Investing Articles
Here’s why H1 results could boost the AstraZeneca share price
Investing Articles
As AstraZeneca’s share price dips 4%, is it time for me to buy more?
Investing Articles
The AstraZeneca share price is up 88% in 5 years, but is it just getting started?
Investing Articles
Here’s Buffett’s ‘secret sauce’ to finding the best UK shares to buy today
Investing Articles
Is the UK stock market about to take a dive?
Investing Articles
1 heavyweight FTSE 100 share I’d buy as London retakes its crown
Investing Articles
My top 3 picks today for a £20,000 Stocks and Shares ISA
Investing Articles
Is this FTSE 100 behemoth about to make investors rich all over again?
Top Stocks
5 quality UK stocks to consider buying for the new ‘British ISA’